Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06133322 · ClinicalTrials.gov registry record · NA
Blood Pressure Lowering Strategies to Eliminate Hypertension Disparities (BLESSED)
A NA study of Hypertension, sponsored by Tulane University.
- Recruiting
- Registry status
- NA
- Development phase
- 1,176
- Enrollment target
- 1
- Study location
NCT06133322 is a NA study of Hypertension that is actively recruiting participants, run by Tulane University. The registered enrollment target is 1,176 participants, below the 3,505-participant average among 470 other Hypertension trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06133322, a NA study of Hypertension, is actively recruiting participants, sponsored by Tulane University.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,176 participants
- Enrollment target
- 1
- Study location
Study Summary
The burden of hypertension and related cardiovascular diseases, stroke, and end-stage kidney disease is disproportionately high in Black populations, especially in the South. The Blood Pressure Lowering Strategies to Eliminate Hypertension Disparities (BLESSED) cluster randomized trial aims to test the effectiveness, implementation, and sustainability of a community health worker (CHW)-led multifaceted intervention compared to enhanced usual care for hypertension control in Black communities. In the BLESSED trial, the investigators plan to recruit 1,176 adults with hypertension (approximately 28 per church) from 42 predominantly Black churches in the Greater New Orleans area. The multifaceted intervention will last for 18 months, followed by a post-intervention follow-up visit at 24 months. The BLESSED trial aims to generate evidence regarding the effectiveness, implementation, and sustainability of this CHW-led church-based multifaceted intervention in eliminating hypertension disparities in the United States (US) general population.
Conditions Studied
Interventions
- BEHAVIORAL Behavioral: Evidence-based interventions recommended by the 2017 ACC/AHA hypertension clinical guideline
Study Locations (1)
Louisiana
- Tulane University - New Orleans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,176 participants |
| Start Date | 2023-11-01 |
| Est. Completion | 2027-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06133322
The ClinicalTrials.gov registry entry for NCT06133322 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 1,176 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,505-participant average among 470 other Hypertension trials with a reported enrollment target (66% lower). The listed sponsor is Tulane University, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Behavioral: Evidence-based interventions recommended by the 2017 ACC/AHA hypertension clinical guideline is the first listed.
NCT06133322 reports 1 study location spanning 1 distinct geographic area - top geographies include Louisiana.
Frequently Asked Questions
What is clinical trial NCT06133322 about?
NCT06133322 is a clinical study titled "Blood Pressure Lowering Strategies to Eliminate Hypertension Disparities (BLESSED)". The burden of hypertension and related cardiovascular diseases, stroke, and end-stage kidney disease is disproportionately high in Black populations, especially in the South. The Blood Pressure Lowering Strategies to Eliminate Hypertension Disparities (BLESSED) cluster randomized trial aims to test ...
What is the current status of trial NCT06133322?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,176 participants. The study started on 2023-11-01. Estimated completion is 2027-06-30.
What conditions does trial NCT06133322 study?
This clinical trial studies the following conditions: Hypertension.
What interventions are being tested in trial NCT06133322?
The interventions under investigation include: Behavioral: Evidence-based interventions recommended by the 2017 ACC/AHA hypertension clinical guideline (BEHAVIORAL).
Who is sponsoring clinical trial NCT06133322?
This trial is sponsored by Tulane University, which has 73 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06133322 being conducted?
This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes
RECRUITING · NA
-
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Early Time-Restricted Eating in Older Adults With Hypertension
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.